Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer
Clinical trial NCT04646759 · RECRUITING
Trial details
- NCT number
- NCT04646759
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-14
- Primary completion
- 2028-12-14
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.